Human antibody targeting of coronavirus spike S2 subunit is associated with protection mediated by Fc effector functions.

Saved in:
Bibliographic Details
Title: Human antibody targeting of coronavirus spike S2 subunit is associated with protection mediated by Fc effector functions.
Authors: Muthuraman K; Program in Molecular Medicine, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada.; Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada., Jackman M; Program in Molecular Medicine, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada., Liang Y; Adaptive Biotechnologies, Seattle, Washington, USA., Garrett ME; Adaptive Biotechnologies, Seattle, Washington, USA., Cui H; Program in Molecular Medicine, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada., Nguyen LVH; Program in Molecular Medicine, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada., Ivanochko D; Program in Molecular Medicine, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada., Ye C; Population Health Program, Texas Biomedical Research Institute, San Antonio, Texas, USA., Pino PA; Population Health Program, Texas Biomedical Research Institute, San Antonio, Texas, USA., Hicks A; Population Health Program, Texas Biomedical Research Institute, San Antonio, Texas, USA., Maingot B; Population Health Program, Texas Biomedical Research Institute, San Antonio, Texas, USA., Yusko E; Adaptive Biotechnologies, Seattle, Washington, USA., Benzeno S; Adaptive Biotechnologies, Seattle, Washington, USA., Martínez-Sobrido L; Population Health Program, Texas Biomedical Research Institute, San Antonio, Texas, USA.; International Center for Advancement of Research & Education (I· CARE), San Antonio, Texas, USA., Torrelles JB; Population Health Program, Texas Biomedical Research Institute, San Antonio, Texas, USA.; International Center for Advancement of Research & Education (I· CARE), San Antonio, Texas, USA., Gilbert AE; Adaptive Biotechnologies, Seattle, Washington, USA., Rubin BER; Adaptive Biotechnologies, Seattle, Washington, USA., Keitany G; Adaptive Biotechnologies, Seattle, Washington, USA., Jetha A; Program in Molecular Medicine, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada., Julien J-P; Program in Molecular Medicine, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada.; Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada.; Department of Immunology, University of Toronto, Toronto, Ontario, Canada.
Source: Journal of virology [J Virol] 2025 Dec 23; Vol. 99 (12), pp. e0152325. Date of Electronic Publication: 2025 Nov 12.
Publication Type: Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: American Society For Microbiology Country of Publication: United States NLM ID: 0113724 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-5514 (Electronic) Linking ISSN: 0022538X NLM ISO Abbreviation: J Virol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1098-5514
DOI:10.1128/jvi.01523-25